Predicting Drug-Induced Cardiotoxicity
Conference - Philadelphia, Pennsylvania
Cambridge Healthtech Institute’s fifth annual conference on Predicting Drug-Induced Cardiotoxicity elaborates on the mechanisms underlying cardiotoxicity, the use of stem cells, ion-channel assays, computational tools and models for early cardiac safety assessments and also delve into details for screening biological drugs, like monoclonal antibodies, antibody drug conjugates, fusion proteins and others. The pre-conference courses related to cardiac safety will also offer more in-depth education and networking opportunities with experts in the field. The CRO panel will include scientific experts from Contract Research Organizations, who will share their views on the technologies and trends that will impact cardiac safety testing going forward.
Chairperson: Gary Gintant, Ph.D., Senior Group Leader, Department of Integrative Pharmacology, Global Pharmaceutical Research & Development, Abbott Laboratories
(Photo courtesy of http://www.worldpharmacongress.com/cto/)
Tuesday, June 5, 2012 to Wednesday, June 6, 2012
Loews Philadelphia hotel, Philadelphia, Pennsylvania
Contact: Nilufer Donmez (ndonmez@healthtech)
Phone: 781-247-6257
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.